AbbVie to Present at the Bank of America Securities Healthcare Conference
AbbVie (NYSE: ABBV) will participate in the Bank of America Securities Healthcare Conference on May 13, 2026, with management appearing in a fireside chat at 1:20 p.m. Central Time.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
AbbVie (NYSE: ABBV) will participate in the Bank of America Securities Healthcare Conference on May 13, 2026, with management appearing in a fireside chat at 1:20 p.m. Central Time. A live audio webcast will stream on AbbVie’s Investor Relations website, with an archive available later that day.
Details
News Market Reaction – ABBV
On May 6, the day this news came out, ABBV closed 0.52% below the previous close.
Data tracked by StockTitan Argus for the May 6 session.
Key Figures
- Conference fireside chat time
- 1:20 p.m. Central Time
- Scheduled time for AbbVie’s fireside chat at the conference on May 13, 2026
Historical Context
-
Long-term real-world and clinical data for risankizumab and upadacitinib in IBD.
-
Phase 1 and preclinical data for NIM-1324 showing target engagement and safety.
-
Allergan Aesthetics charitable campaign tied to new Allē member sign-ups.
-
Q1 net revenue growth, key product strength, and raised 2026 EPS guidance.
-
FDA application for upadacitinib in severe alopecia areata based on Phase 3 data.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, neuroscience and oncology – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X and YouTube.
Media: Gabby DioGuardi | Investors: Liz Shea |
View original content:https://www.prnewswire.com/news-releases/abbvie-to-present-at-the-bank-of-america-securities-healthcare-conference-302763216.html
SOURCE AbbVie
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.